Emerging strategies for exploiting cannabinoid receptor agonists as medicines.

Author(s): Pertwee RG

Institute of Medical Sciences, University of Aberdeen, Foresterhill, UK. [email protected]

Subject: General View the study

Abstract:

Medicines that activate cannabinoid CB(1) and CB(2) receptor are already in the clinic. These are Cesamet (nabilone), Marinol (dronabinol; Delta(9)-tetrahydrocannabinol) and Sativex (Delta(9)-tetrahydrocannabinol with cannabidiol). The first two of these medicines can be prescribed to reduce chemotherapy-induced nausea and vomiting. Marinol can also be prescribed to stimulate appetite, while Sativex is prescribed for the symptomatic relief of neuropathic pain in adults with multiple sclerosis and as an adjunctive analgesic treatment for adult patients with advanced cancer...

Source: British Journal of Pharmacology
Share Tweet

More medical studies related to General:

View all medical studies >>

Subscribe for daily cannabis news, announcements, and business insights.

https://progressive.ua

Buy Trenaver Enantat online in USA

https://www.kompozit.ua/